Stifel Nicolaus Trims Surgery Partners (NASDAQ:SGRY) Target Price to $36.00

Surgery Partners (NASDAQ:SGRYGet Rating) had its target price lowered by Stifel Nicolaus from $44.00 to $36.00 in a report issued on Tuesday, The Fly reports.

A number of other analysts also recently issued reports on SGRY. Cowen lowered their price target on shares of Surgery Partners to $35.00 in a report on Wednesday, November 16th. SVB Leerink lowered their price target on shares of Surgery Partners from $55.00 to $40.00 and set an outperform rating on the stock in a report on Tuesday. Citigroup lowered their price target on shares of Surgery Partners from $49.00 to $38.00 and set a buy rating on the stock in a report on Wednesday, November 9th. StockNews.com downgraded shares of Surgery Partners from a hold rating to a sell rating in a report on Saturday, November 5th. Finally, Royal Bank of Canada decreased their price objective on shares of Surgery Partners from $62.00 to $58.00 and set an outperform rating on the stock in a report on Thursday, November 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus price target of $47.00.

Surgery Partners Stock Performance

Shares of NASDAQ SGRY opened at $27.49 on Tuesday. The company’s fifty day moving average price is $26.02 and its 200 day moving average price is $31.61. Surgery Partners has a 1 year low of $20.46 and a 1 year high of $63.87. The company has a market capitalization of $2.47 billion, a PE ratio of -78.54 and a beta of 2.82. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.07 and a current ratio of 1.18.

Insider Transactions at Surgery Partners

In other Surgery Partners news, Director Brent Turner purchased 10,000 shares of the firm’s stock in a transaction dated Monday, November 21st. The shares were purchased at an average cost of $24.50 per share, with a total value of $245,000.00. Following the completion of the purchase, the director now owns 57,701 shares in the company, valued at approximately $1,413,674.50. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Laura L. Brocklehurst sold 4,338 shares of the firm’s stock in a transaction dated Wednesday, November 9th. The shares were sold at an average price of $22.96, for a total value of $99,600.48. Following the transaction, the insider now directly owns 41,424 shares of the company’s stock, valued at $951,095.04. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Brent Turner purchased 10,000 shares of the firm’s stock in a transaction dated Monday, November 21st. The stock was acquired at an average cost of $24.50 per share, for a total transaction of $245,000.00. Following the completion of the purchase, the director now owns 57,701 shares of the company’s stock, valued at approximately $1,413,674.50. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 4,671 shares of company stock valued at $109,474. Corporate insiders own 3.30% of the company’s stock.

Institutional Investors Weigh In On Surgery Partners

Several hedge funds and other institutional investors have recently bought and sold shares of the company. PNC Financial Services Group Inc. increased its position in Surgery Partners by 34.7% during the first quarter. PNC Financial Services Group Inc. now owns 1,195 shares of the company’s stock worth $66,000 after purchasing an additional 308 shares during the last quarter. Wolverine Asset Management LLC increased its position in Surgery Partners by 2.5% during the second quarter. Wolverine Asset Management LLC now owns 16,541 shares of the company’s stock worth $478,000 after purchasing an additional 400 shares during the last quarter. Connacht Asset Management LP increased its position in Surgery Partners by 4.3% during the first quarter. Connacht Asset Management LP now owns 10,108 shares of the company’s stock worth $556,000 after purchasing an additional 420 shares during the last quarter. Arizona State Retirement System lifted its stake in shares of Surgery Partners by 7.7% in the 1st quarter. Arizona State Retirement System now owns 9,562 shares of the company’s stock valued at $526,000 after purchasing an additional 682 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its holdings in shares of Surgery Partners by 139.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,379 shares of the company’s stock worth $32,000 after purchasing an additional 804 shares during the period.

Surgery Partners Company Profile

(Get Rating)

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Recommended Stories

The Fly logo

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.